Atlas Trials

Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD Effects in Male Volunteers

Clinical trial NCT02914262 · COMPLETED

Trial details

NCT number
NCT02914262
Sponsor
Aerpio Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
IBD
Start date
2016-08-01
Primary completion
2016-11-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.